1) the outer to outer margins of the trophoblastic tissue were measured in all cases 2) in ectopics presenting with a well-defined gestational sac the inner to inner margins of the trophoblastic ring denoting the celomic (chorionic) cavity were also measured 3) in women with evidence of hematosalpinx the measurements were taken between the inner margins of the Fallopian tube
We recorded the maximum and mean values of each measurement.
The operating surgeons were blinded to the detailed measurements taken for the purpose of the study. The size of ectopic was estimated subjectively during visual assessment on the affected fallopian tube at surgery. Results: A total of 105 women were diagnosed with a tubal ectopic pregnancy on ultrasound examination out of which 71/105 (67.6%) were managed surgically. We found a significant (p<0.01) positive correlation between all ultrasound measurements and the size of tubal ectopic pregnancy as reported during surgery. In the absence of a hematosalpinx, the mean total outer diameter of ectopic pregnancy had the highest positive correlation with the size of tubal ectopic at surgery (r=0.65, P<0.001). In cases complicated by hematosalpinx, the mean diameter of the tube was the only variable which correlated significantly (p<0.001) with the estimated size of ectopic pregnancy at surgery.
Conclusions:
The mean size of hematosalpinx and the total outer mean diameter of ectopic pregnancy on ultrasound correlate better with surgical findings than the size of celomic cavity. These measurements should become part of a standardised approach to the ultrasound assessment of ectopic pregnancies.
OP16.08
The proportion of women with a histological diagnosis of molar pregnancy who are diagnosed with ultrasound prior to uterine evacuation Objectives: The aim of this study is to assess the accuracy of the diagnosis of hydatidiform mole with transvaginal ultrasound (TVS) prior to evacuation and histological examination of the removed products.
Methods: A retrospective analysis was performed of all partial and complete molar pregnancies that were diagnosed at Nepean Hospital early pregnancy unit between 2011 and Feb 2017, both sonographically and histologically. A total of 7,193 women were seen in the Early Pregnancy Unit during that time. 40/7193 (0.01%) had gestational trophoblastic disease (GTD) histologically. The true sensitivity and PPV was then calculated for ultrasound diagnosis of hydatidiform mole from those that had been proven histologically. Results: A total of 43 patients were included in the study. Of the 43 cases, 40 (0.01%) were confirmed to have GTD. Twenty-nine (72.5%) were suspected to have GTD on TVS prior to evacuation and examination of the removed products. Histologically, 25 (62.5%) had a complete molar pregnancy (CMP). Eighteen (72%) were suspected on TVS. Fifteen were histologically confirmed to have partial molar pregnancies (PMP). Six (4%) were suspected on TVS preoperatively. The overall sensitivity was 59% with a PPV of 90% for ultrasound diagnosis of a molar pregnancy. The CMP sensitivity was 72% and PPV 97.3% and for PMP 37% and 67% respectively. Conclusions: Ultrasonography is more accurate in diagnosing CMP than PMP. The overall ultrasound sensitivity in our unit is 59% for preoperative diagnosis. However, histology is still the gold standard for the diagnosis of hydatidiform mole.
OP16.09
Development and validation of a clinical scoring system for predicting the effectiveness of misoprostol treatment for early pregnancy failure O. Limonad, H. Sharabi, I. Bruchim, A. Shrim
Technion Israel, Neve Yarak, Israel
Objectives: To develop a scoring system and to evaluate its accuracy in prediction of Misoprostol treatment outcome in the management of early pregnancy failure. Methods: We conducted a retrospective cohort study and retrospective validation cohort study including all patients discharged between 2013 and 2014 from the gynecologic emergency department (ED) with a diagnosis of early pregnancy failure who had medical treatment with Misoprostol 800 mcg vaginally. Clinical data were pulled together to identify predictors that distinguished successful from no response. Scoring system was then retrospectively applied to a second population to evaluate its accuracy in predicting Misoprostol treatment outcome.
Multivariate logistic regression was performed to identify predictive factors associated with treatment response and these were assigned integer points to establish a scoring system that was stratified into low, moderate, and high probability levels of effectiveness. The sensitivity, specificity and accuracy of the level of decision were then computed. Results: The derivation sample included 115 records, with six factors found to be most predictive of Misoprostol treatment effectiveness: multiparty, previous abortion, gestational age, vaginal bleeding, abdominal pain and mean sac diameter, yielding a score of 0-10. Retrospective validation was performed on 115 participants. In the derivation and validation cohorts, successful treatment was found in, respectively, 7% and 9% of the low probability group, 54% and 56% of the moderate probability group, and 84% and 82% of the high probability group. Conclusions: Based on these results the suggested score, derived from our local database, can be utilised as an adjunct to clinical decision making in questionable cases of first-trimester pregnancy failure. While we acknowledge that there are various limitations to our model, we believe we have established a novel scoring system that has the potential to be improved with further data and be very practical in a long run.
